*Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
†Department of Clinical Biochemistry, Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
‡Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
§Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
Supported by Rigshospitalet Research Council, Region Hovedstaden, The Lundbeck Foundation, The Novo Nordisk Foundation, and The Danish National Research Foundation grant 126. The study was designed, conducted, analyzed, and written by the authors without involvement of any commercial party.
J.G.: Honoraria for consulting and presenting paid to his institution from Gilead, Abbvie, ViiV, BMS, MSD, Janssen, and Medivir. T.B.: Personal fees from Bristol Myers Squibb (BMS) and from Gilead and nonfinancial support from BMS and from Gilead. S.D.N.: Unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, and Rigshospitalet Research Council. Travelling grants from Gilead, MSD, BMS, and GSK/ViiV. Advisory board activity for Gilead and GSK/ViiV. The remaining authors have no conflicts of interests to disclose.